Clue

Funding 💰
Total $55.4M
Select investors Balderton Capital, Union Square Ventures, Atlantic Labs, Mosaic Ventures, Future Positive Capital, Groupe Arnault, Molten Ventures, Nokia Growth Partners
Key people 🧑🤝🧑
- Ida Tin - Co-founder & Chairwoman
- Hans Jakob Raffauf - Co-founder
- Moritz von Buttlar - Co-founder
- Mike LaVigne - Co-founder
- Audrey Tsang - Co-CEO
- Carrie Walter - Co-CEO
- Greg Ryzhov - CTO
- Sarah Ottawa - Head of People
- Amanda Shea PhD - Head of Science
Highlights ⭐
- Large user base: As of April 2023, Clue is used by 11 million people in over 190 countries. Also, it has 4.5 million monthly article readers.
- Users love it: The Clue app has a 4.8-star score based on over 2 million ratings.
- FDA-cleared digital contraceptive: Clue Birth Control uses tracked period start dates to allow women to monitor their fertility and prevent pregnancy. It combines the user's menstrual cycle data with a mathematical model derived from clinical research data to predict which days they are at high or low risk for pregnancy.
- A femtech founder: One of Clue's co-founders, Ida Tin, coined the term femtech in 2016 to define the group of technologies that are designed to support and advance women's healthcare.
- Media love: Clue had its fair share of media exposure, including in such publications as Cosmopolitan, Bloomberg, Wired, TechCrunch, Business Insider, and Glamour, to name a few.
Video ▶️
Awards & Recognitions 🏆
- 2016 American College of Obstetrics and Gynecology (ACOG) rated Clue the number one period tracking app
- 2015 Wired: Among the Hottest Startups
Quotes 💬
“
Clue has positioned itself as a category-defining product within femtech. They have built a friendly, user-centric product rooted in an evidence-based and medical-grade level of rigour with half the planet as potential customers over their lifetime.
— Colin Hanna, Partner at Balderton 🔗
Last update: April 26, 2023
Disclaimer: We can not guarantee that the information on this page is 100% correct. more